You are here

INCREASING AVAILABILITY OF EMULSION ADJUVANTS VIA SYNTHETIC BIOLOGY

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 75N93022C00038
Agency Tracking Number: 75N93022C00038
Amount: $2,996,311.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: 106
Solicitation Number: PHS-2022-1
Timeline
Solicitation Year: 2021
Award Year: 2022
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
137 EDGEMOOR DR
LEXINGTON, KY 40503-2006
United States
DUNS: 080540683
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 CHASE KEMPINSKI
 (202) 538-1191
 chase.kempinski@enepret.com
Business Contact
 Chase Kempinski
Phone: (202) 538-1191
Email: chase.kempinski@enepret.com
Research Institution
N/A
Abstract

Squalene-based oil-in-water emulsions, such as MF59, have been shown to demonstrate adjuvant activity in a variety of vaccine settings, including seasonal influenza vaccine. The awardee seeks to develop a mimic of MF59 using squalene that has been sustainably synthesized by yeast cultures. This adjuvant will be tested in preclinical studies and advanced toward large production capacity.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government